Synergistic inhibition of cancer cell viability and suppression of HIFI a by CDK4 inhibitors and HSP90 inhibitors across cancer types

被引：0
|
作者：
Zhao, Shuai [1 ]
Zhou, Lanlan [1 ]
Dicker, David T. [1 ]
El-Deiry, Wafik S. [1 ]
机构：
[1] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-2654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2654
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Synergistic activity of Hsp90 inhibitors and anticancer agents in pancreatic cancer cell cultures
    Simonas Daunys
    Daumantas Matulis
    Vilma Petrikaitė
    Scientific Reports, 9
  • [2] Synergistic activity of Hsp90 inhibitors and anticancer agents in pancreatic cancer cell cultures
    Daunys, Simonas
    Matulis, Daumantas
    Petrikaite, Vilma
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [3] Effects of Different Types of Hsp90 Inhibitors in Pancreatic and Colorectal Cancer Cell Lines
    Mayor-Lopez, L.
    De Torre, C.
    Tristante-Barrenechea, E.
    Carrasco-Garcia, E.
    Garcia-Morales, P.
    Saceda, M.
    Carballo, F.
    Martinez-Lacaci, I.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S231 - S232
  • [4] CDK4/6 inhibitors in breast cancer
    Dukelow, Tim
    Kishan, Divya
    Khasraw, Mustafa
    Murphy, Conleth G.
    ANTI-CANCER DRUGS, 2015, 26 (08) : 797 - 806
  • [5] Hsp90 inhibitors as novel cancer chemotherapeutic agents
    Neckers, L
    TRENDS IN MOLECULAR MEDICINE, 2002, 8 (04) : S55 - S61
  • [6] Hsp90 inhibitors in breast cancer: A systematic review
    Zagouri, Flora
    Sergentanis, Theodoros N.
    Chrysikos, Dimosthenis
    Papadimitriou, Christos A.
    Dimopoulos, Meletios-Athanassios
    Psaltopoulou, Theodora
    BREAST, 2013, 22 (05): : 569 - 578
  • [7] Inhibitors of HSP90 and other chaperones for the treatment of cancer
    Dymock, BW
    Drysdale, MJ
    McDonald, E
    Workman, P
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (06) : 837 - 847
  • [8] Hsp90 inhibitors and drug resistance in cancer: The potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs
    Lu, Xiangyi
    Xiao, Li
    Wang, Luan
    Ruden, Douglas M.
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (08) : 995 - 1004
  • [9] Anti-cancer effect by combination treatment of CDK and HSP90 inhibitors through HIF1α inhibition
    Zhao, Shuai
    Zhou, Lanlan
    Dicker, David T.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2018, 78 (13)
  • [10] Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
    Piezzo, Michela
    Cocco, Stefania
    Caputo, Roberta
    Cianniello, Daniela
    Di Gioia, Germira
    Di Lauro, Vincenzo
    Fusco, Giuseppina
    Martinelli, Claudia
    Nuzzo, Francesco
    Pensabene, Matilde
    De Laurentiis, Michelino
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 23
12345